Paclitaxel and Alisertib in Recurrent Ovarian Cancer-In Reply

JAMA Oncol. 2019 Jun 1;5(6):910-911. doi: 10.1001/jamaoncol.2019.0562.
No abstract available

Publication types

  • Comment

MeSH terms

  • Azepines
  • Breast Neoplasms*
  • Female
  • Humans
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms*
  • Paclitaxel
  • Pyrimidines

Substances

  • Azepines
  • MLN 8237
  • Pyrimidines
  • Paclitaxel